Welcome Message
Dear Friends and Colleagues,
It gives me great pleasure to invite you to the 8th UAE International Conference on Antimicrobial Resistance (ICAMR), which will be held on February 21 and 22, 2025 in Dubai, United Arab Emirates.
ICAMR 2025 promises to be an enriching scientific and educational gathering, showcasing the latest advances in research and practice through presentations and interactive discussions. With in-depth, high-quality scientific content, the conference will focus on the field of Antimicrobial Resistance. This event is proudly organized by the National Antimicrobial Resistance Committee in the UAE.
We believe that ICAMR 2025 will provide an exceptional opportunity for attendees to share and gain knowledge and experience across a wide spectrum of topics related to microbiology, infectious diseases, infection control, and antimicrobial stewardship. Additionally, it will offer a unique platform to meet and engage with experts and innovative educators in the field.
We look forward to welcoming you to the 8th ICAMR 2025.
Sincerely,
Dr. Najiba M Abdulrazzaq
Consultant Internist
Head of Medical Dept.
Al Kuwait Hospital Dubai
Head of Central IPC Committee, MOHAP
National AMR Committee Co-Chair
Dubai, UAE
2024 Global Health Leader
2024 Supported by
2024 In Collaboration with
Endorsed By
Scientific & Organizing Committee
Dr. Najiba M Abdulrazzaq
Consultant Internist
Head of Medical Dept.
Al Kuwait Hospital Dubai
Head of Central IPC Committee, MOHAP
National AMR Committee Co-Chair
Dubai, UAE
Dr. Ahmed Al Hammadi
Consultant
President, Emirates Infectious Disease Society
Infectious Disease
Tawam Hospital
Al Ain, UAE
Dr. Ashraf El Houfi
Chairman of the Infection Control-
Committee Dubai Hospital
Consultant ICU
Dubai Hospital
Dubai, UAE
Ms. Abeer Rajeh Khalil
RN-BSN
Infection control Expert
Quality and accreditation Department
Emirates Health Services
Dubai, UAE
Ms. Husna Nazar
Medical Secretary
Al Kuwait Hospital Dubai
Dubai, UAE
Mr. Joseph Tannous
Infection control Specialist
Central Infection Control
Emirates Health Services
Dubai, UAE
Dr. Sohanlal Thiruvoth
MBBS, MD, DNB
DipRCPath, Fellowship in Infectious Diseases, CIC
Head Infection Control Unit
Kuwait Hospital , Sharjah
Sharjah, UAE
Dr. Jens Thomsen
Associate Professor (Adjunct)
Public Health and Epidemiology
Khalifa University
AbuDhabi, UAE
Dr. Zulfa Al Deesi
Acting Head of Pathology Section
Head of Microbiology and infection Control Unit
Latifa Women and Children Hospital
Pathology & Genetics Department
Dubai, UAE
Dr. Ahmed Al Hammadi
Consultant
President, Emirates Infectious Disease Society
Infectious Disease
Tawam Hospital
Al Ain, UAE
Dr. Layla Al-Dabal
BSc, MD MSc (UK) FRCP (UK)
Consultant
Medical-Infectious Diseases
Rashid Hospital
Dubai, UAE
Dr. Nehad Alshirawi
Intensive Care Consultant and
Head of ICU Department
Intensive Care
Al Fujairah Hospital
Fujairah, UAE
Prof. Ashraf El Houfi
Chairman of the Infection Control-
Committee Dubai Hospital
Consultant ICU, Dubai Hospital
Dubai, UAE
Ms. Duaa Salem Jawhar
Master in Clinical Pharmacy
American Board Infectious Disease
Infectious Disease Clinical Pharmacist
Co-leader Antimicrobial Stewardship programe
Pharmacy Department
Saqr Hospital
Ras Al Khaimah, UAE
Dr. Ahmad Lutfi Subhi
Consultant, Infectious Diseases
Al Qassimi Hospital
Emirates Health Services
Sharjah, UAE
Mr. Joseph Tannous
Infection Control Consultant
Central Infection Control
Emirates Health Services
Dubai, UAE
Mr. Elias Tannous
BSN-MBA-CIC
Manager, Infection Control
Co-chair Infection Control Committee
Quality and Patient Safety Institute
Cleveland Clinic
Abu Dhabi, UAE
Dr. Sohanlal Thiruvoth
MBBS, MD, DNB
DipRCPath, Fellowship in Infectious Diseases, CIC
Head Infection Control Unit
Kuwait Hospital , Sharjah
Sharjah, UAE
Dr. Jehad Abdalla
ID Consultant, SKMC Hospital
Chair of ASP Committee in SEHA
Abu Dhabi, UAE
Dr. Nawal Al Kaabi
Acting Chief Medical Officer
Pediatric Infectious Disease Consultant
Medical Institute – Medical Affairs
Sheikh Khalifa Medical City
Abu Dhabi, UAE
Ms. Fatima Saeed AL Memari
Infection Control Officer
Prevention and Control of Infection Department
Ibrahim Bin Hamad Obaidallah Hospital & Obaidallah Geriatric Hospital
Ras Al Khaimah, UAE
Dr. Majid Al Shamrani
Executive Director
Infection Prevention and Control Program
King Abdulaziz Medical City
Ministry of National Guard Health Affairs
Riyadh, KSA
Ms. Hajar Ali Aldhanhani
RN, BSN, CIC
Infection Prevention & Control Manager
Tawam Hospital
Al Ain, UAE
Beneditta Allegranzi
MD & DTM&H, Adjoint Professor
Unit Head, Infection Prevention and Control (IPC) Unit
Technical Lead, IPC Taskforce and the Global IPC Network
Integrated Health Services
UHC/Life Course, World Health Organization HQ
Geneva, Switzerland
Prof. Arunaloke Chakrabarti
Director, Microbiology
Doodhadhari Burfani Hospital &
Research Institute
Haridwar, India
Dr. Pramod Chhabrani
Specialist, Clinical Microbiologist
Medicine
Al Kuwait Hospital, Emirates Health Services
Dubai, UAE
Dr. Rania El-Lababidi
Pharm.D, EMHA, BCPS (AQ-ID), AAHIVP
Senior Manager
Pharmacy Education and Training
Co-Director, Antimicrobial Stewardship Program
Department of Pharmacy Services
Cleveland Clinic
Abu Dhabi, UAE
Prof. Dean Everett
Member, Scientific Committee, ESCM
College of Medicine and
Health Sciences, Khalifa University
Abu Dhabi, UAE
Prof. Souha S. Kanj
MD, FACP, FIDSA, FRCP, FESCMI, FECMM
Professor of Medicine
Associate Dean for Global Affairs
Head, Division of Infectious Diseases
Chairperson, Infection Control Program
Co-Director, Antimicrobial Stewardship Program
American University of Beirut Medical Center, Lebanon
Consultant Professor, Duke University Medical Center, USA
Honorary Dr., Radboud University Medical Center, NL
Prof. Martin Kiernan
Visiting Professor, Infection Prevention
Richard Wells Research Centre
University of West London
London, UK
Dr. Jihad Mallat
Interim Institute Chair
Medical-Surgical Critical Care
Critical Care Institute
Cleveland Clinic
Abu Dhabi, UAE
Dr. Farah Al Marzooq
Asst. Professor, Microbiology
Medical Microbiology & Immunology
College of Medicine and Health Sciences
UAE University
Al Ain, UAE
Dr. Godfred A. Menezes
Professor & Chairperson
Medical Microbiology &
Immunology Medical Microbiology & Immunology
RAK College of Medical Sciences (RAKCOMS)
RAK Medical & Health Sciences University (RAKMHSU)
Ras Al Khaimah, UAE
Prof. Mohd Saberi Mohamad
Department of Genetics and Genomics
College of Medicine and Health Sciences
United Arab Emirates University
Al Ain, Abu Dhabi, UAE
Dr. Anju Nabi
Head of Immunology &
Senior Specialist Microbiologist
Dubai Health Authority
President
Emirates Society for Clinical Microbiology
Dubai, UAE
Dr. Emmanuel Fru Nsutebu
Chair of Division
Tropical and Infectious Disease Division
Sheikh Shakhbout Medical City
Abu Dhabi, UAE
Dr. Lisa Oakley
Epidemiologist
International Infection Control Program
Division of Healthcare Quality Promotion
National Center for Emerging and
Zoonotic Infectious Diseases
Centers for Disease Control and Prevention (CDC)
Atlanta, USA
Dr. Ali Omrani
Senior Consultant, Infections Disease
Hamad Medical Corporation
Doha, Qatar
Dr. Aiman Ramadan
MD, PhD, MPH, MSc, FACE
Advisor, Health Surveillance
Infection Prevention & Control Department
KAMC, Riyadh
Ministry National Guard Health Affair
Asst Professor of Epidemiology & Biostatistics
CPHHI, KSAU-HS
College of Public Health and Health Informatics
King Saud bin Abdulaziz University for Health Sciences
Riyadh, KSA
Ms. Clare Roche
Research Manager
Economist Impact
Dubai, UAE
Prof. Abiola Catherine Senok
Professor Microbiology & Infectious Diseases
Chair, Basic Medical Sciences Department
College of Medicine
Mohammed Bin Rashid University Of Medicine and Health Sciences
Dubai, UAE
Dr. Ahmad Lutfi Subhi
Infectious Disease Consultant
Al-Qassimi Hospital, EHS
Sharjah, UAE
Mr. Elias Tannous
BSN-MBA-CIC
Manager, Infection Control
Co-chair Infection control committee
Quality and Patient Safety Institute
Cleveland Clinic
Abu Dhabi, UAE
Dr. Stefan Weber
Director of Medical Operations Purelab / Union 71
Sheikh Khalifa Medical City
Abu Dhabi, UAE
Nezar Bahabri
Chief Medical Officer
Future Care Home Health Care
Jeddah, KSA
Souha Kanj
MD, FACP, FIDSA, FRCP, FESCMI, FECMM
Professor of Medicine
Associate Dean for Global Affairs
Head, Division of Infectious Diseases
Chairperson, Infection Control Program
Co-Director, Antimicrobial Stewardship Program
American University of Beirut Medical Center, Lebanon
Consultant Professor, Duke University Medical Center, USA
Honorary Dr., Radboud University Medical Center, NL
Safwan Abdallah
Co-Founder
MicroSafe
Dubai, UAE
Marc Gitzinger
Co-Founder & Chief Executive Officer
BioVersys
Basel, Switzerland
Pramod Chhabrani
Specialist, Clinical Microbiologist
Medicine
Al Kuwait Hospital, Emirates Health Services
Dubai, UAE
Jehad Abdallah
ID Consultant, SKMC Hospital
Chair of ASP Committee in SEHA
Abu Dhabi, UAE
Ahmad Subhi
Infectious Disease Consultant
Al-Qassimi Hospital, EHS
Sharjah, UAE
Ms. Abeer Rajeh Khalil
RN-BSN
Infection control Expert
Quality and accreditation
Department
Emirates Health Services
Dubai, UAE
Mr. Joseph Tannous
Infection control Specialist
Central Infection Control
Emirates Health Services
Dubai, UAE
Scientific Program
Conference Main Topics
- Antimicrobial Stewardship Programs
- AMR: updates, novel technology and artificial intelligence
- Challenges and research priorities to combat AMR
- Prevention of healthcare-associated infections
- Surveillance of multidrug resistance organisms
- Implementation science for infection control
- Environmental disinfection in healthcare settings
- New antimicrobial therapies
Target Specialties:
- Infection disease physicians
- Internal medicine physicians
- Microbiologists
- Pharmacists
- Infection control practitioners
- Critical care physicians
- Lab technicians
- Quality officers
- Public health officers
- Internal medicine specialists
- Family and primary care physicians
- Medical informatics
- Nurses, nurse practitioners
- Researchers
- Biomedical engineers
- Hospital and corporate administrators and executives
Learning Objectives
- Antimicrobial Stewardship Programs: interventions and outcomes
- UAE AMR surveillance updates
- GCC: experience and strategies to combat AMR
- Strengthening country readiness for pandemics
- AMR in mass gathering and implications for public health
- Strategies, technology and artificial intelligence to combat AMR
- Challenges and research priorities to combat AMR
- Implementation of science in the fight against HAI
- Innovative approach to prevent MDRO
- Prevention and management of healthcare-associated infections
- Business case for Infection, Prevention and Control Programs
- Environmental hygiene for patient safety
- Improving healing environment in building projects
- Certification: preparation and tips for infection preventionists
Abstract Submission
Abstract Submission
To submit an abstract, please read all of the instructions below.
You are invited to submit an abstract for the 8th UAE International Conference on Antimicrobial Resistance (ICAMR) on 21 & 22 February 2025.
Abstract Submission deadline until: Sunday, 12 January 2025 – 11:59 PM
Notification on Acceptance/Rejection: Between 15 to 20 January 2025 – 11:59 PM
Please note that only electronic submissions are accepted.
Language & Content
All abstracts must be submitted in English using the online submission form on website with a limit of 2,245 characters (approx. 300 words).
General Conditions
-
- Abstracts must be submitted maximum by Sunday, 12 January 2025 – 11:59 PM.
- Abstracts are accepted as Poster presentations only.
- All accepted abstracts will be presented as posters on 22 February 2025.
- Withdrawal of abstracts can only be accepted if notified in writing. It is possible to withdraw an abstract 14 days after notification on acceptance.
- If selected, it is the responsibility of the presenter to bear his travel and accommodation expenses.
Presenting Author and Registration
- Please verify that your email address (submitter and presenting author) is correct as it will be used for contacting you after the review process.
- Disclosure: Abstract submitter and presenter are required to disclose any conflict of interest.
- Ensure that all co-authors approve the abstract submission, publication, and potential presentation.
- All presenters should be registered to the conference before 10 February 2025.
- Abstract submitters must consent to the Policies of Abstract Submission.
- National Committee of AMR reserves the right to exclude any abstract from the scientific program that is not followed by a participant registration at the latest 14 days after notification on acceptance.
Contents of your Abstract
- Original works and Case Reports about Microbiology, Infectious Disease, Infection Control, and Antimicrobial Resistance will be accepted.
- The abstract text body is limited to 2,245 characters (Approx. 300 words) including spaces. (Please do not include the title and the author’s information in the text body [names and affiliations], this information will be required in the web form)
- The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract title in CAPITAL LETTERS. No full stop at the end.
- There are no limitations on the number of abstracts that an individual can submit. However, one individual can only present a maximum of 2 abstract (independent of the format) during the entire conference. If you have more than 2 abstracts accepted, you will be obliged to identify alternate presenters for any abstract above the first two.
- The abstract must include the following:
Aim: Clearly state the purpose of the abstract.
Methods: Describe your selection of observations or experimental subjects clearly.
Results: Present, your results in a logical sequence in text, table and illustrations.
Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them. - All abbreviations must be defined in first use.
- No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of the author(s) and their institution(s), when you submit your abstract online
- Statements such as “results will be discussed” or “data will be presented” cannot be accepted.
- Use of brand names for all references to products or companies, generic names must be used. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only. Conference scientific committee reserves the right to replace any brand name with a generic name without further notice.
- Images that are uploaded to follow the abstract are not guaranteed inclusion in the conference materials.
Conference Venue
ICAMR 2024 Videos On-Demand
7th ICAMR – Day 1 – Hall A – 23 Feb 2024
7th ICAMR – Day 1 – Hall B – 23 Feb 2024
7th ICAMR – Day 2 – 24 Feb 2024
2024 Sponsors
Why sponsor the Conference?
The 8th UAE International Conference on Antimicrobial Resistance (ICAMR) provides a comprehensive range of sponsorship packages for you to choose from. Packages are designed to increase your exposure and showcase your organization. You will benefit from many opportunities to build relationships with existing clients and meet prospective clients in this dynamic field.
What sponsorship packages are available?
Sponsorship packages are offered at five levels – Ultimate, Diamond, Platinum, Gold and Titanium, so there’s something to suit all budgets.
Main Sponsorship packages include:
- Exhibition space
- Speaking opportunity
- Delegate registrations
Take up one of our exclusive branding opportunities
These include sponsoring:
- Delegate bags
- Lanyards or Badges
- Pocket program
- Mobile app
- Badge activation counter
Find out about our full range of exclusive sponsorship packages by filling out the form.
Book a stand
Exhibiting at the 8th UAE International Conference on Antimicrobial Resistance (ICAMR) presents multiple benefits to your company, including providing a comprehensive platform for targeted promotion and brand exposure at the event where leading members in the field of antimicrobial resistance and infectious diseases are networking, to talk about educational opportunities and future developments.
A separate exhibition covering pharmaceutical products, diagnostics and lab tests, lab ware, medical equipment, and instruments, will take place during the conference and at the same venue.
Booking is on a first-come-first-served basis.
Read about our exhibition package here.
